Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 603-373-3 | CAS number: 129909-90-6
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
No other available studies
Effect on fertility: via oral route
- Dose descriptor:
- NOAEL
- 73.2 mg/kg bw/day
Additional information
The parental systemic NOAEL for the 2-generation reproduction study in rats (Astroff, 1998) was 100 ppm (equivalent to 6.4/7.3 mg/kg/day [males/females]), based on decreased body weight and body weight gains seen at higher doses. There were no reproductive effects observed, thus the reproductive NOAEL was considered to be the maximum dose tested, 1000 ppm (equivalent to 73.2/84.0 mg/kg/day [males/females). The offspring NOAEL was considered to be 100 ppm (equivalent to 6.4/7.3 mg/kg/day [males/females]) based on decreased pup body weights and overall decreased body weights throughout treatment.
Short description of key information:
7.8.1 Toxicity to reproduction:
KS - 2gen.rat. Astroff, 1998. KL.1, NOAEL reproductive M: 73.2, F: 84 mg/kg/day; Offspring M: 6.4, F: 7.3 mg/kg/day
Effects on developmental toxicity
Description of key information
7.8.2 Developmental toxicity / teratogenicity:
KS - Terat.rat. Astroff & Young, 1999. KL.2, NOAEL Maternal and offspring 15 mg/kg/day
Effect on developmental toxicity: via oral route
- Dose descriptor:
- NOAEL
- 15 mg/kg bw/day
Additional information
In the developmental rat study (Astroff & Young, 1999) again effects on body weight were observed, with the maternal NOAEL considered to be 15 mg/kg/day. Developmental NOAEL was considered to be 15 mg/kg/day, based on multiple skeletal developmental retardations (including incomplete and unossified bones) observed at higher doses. When these findings are assessed in conjunction with the 2 generation study results, the skeletal retardations are thought not be a lasting adverse effect as foetal viability was not decreased in the 2-generation reproduction study. Furthermore these effects were only observed in the presence of maternal toxicity (reductions in body weight loss), with such effects not associated with any consistent syndrome of developmental effects in the rat (Chernoff, et al., 1988).
Reference:
Chernoff, N., Miller, D.B., Rosen, M.B. & Mattscheck, C.L. (1988). Developmental effects of maternal stress in the CD-1 mouse induced by restraint on single days during the period of major organogenesis. Toxicology., 51., pp 57 -65.
Justification for classification or non-classification
Developmental effects were only observed in the presence of maternal toxicity. No evidence of fertility effects were observed. Therefore amicarbazone has not been classified as teratogenic or causing an adverse effect on fertility.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
